Search
Search Results
##search.searchResults.foundPlural##
-
TYROSINE KINASE INHIBITORS AND INTERFERON
2796PDF: 1390HTML: 3038Cover Letter: 182 -
-
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2315PDF: 963HTML: 1628Fig 1: 167Tab I: 191Cover Letter: 182 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
1952PDF: 776HTML: 196 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2401PDF: 759HTML: 1721 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1541PDF: 1039HTML: 99 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4295PDF: 870HTML: 1299Table1: 165 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1024PDF: 524HTML: 1676Figures: 147Fifures Sanz: 156tables Sanz: 163Untitled: 157 -
Acquired Hemophilia A successfully treated with rituximab
1849PDF: 1094HTML: 1443Figure 1: 151 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1296HTML: 367PDF: 793 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1527PDF: 775HTML: 138 -
WHAT ARE FUNGAL INFECTIONS?
4033PDF: 2310HTML: 27549de Pauw: 212 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3999PDF: 1534HTML: 836 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2168PDF: 1002HTML: 1971Characteristic of study group: 177 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1161PDF: 572HTML: 199 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
3955PDF: 1895HTML: 5192Table 1: 166 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1644PDF: 778HTML: 922cover letter: 247 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1347PDF: 696Suppl. Files: 295Html: 121 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1336PDF: 797HTML: 3103 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1354PDF: 721HTML: 191 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3146PDF: 1683HTML: 1071 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2076PDF: 1298HTML: 3487 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1682PDF: 545HTML: 261 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1866PDF: 1053HTML: 567 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2738PDF: 979HTML: 5497 -
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
1604PDF: 796HTML: 217







